Aramune
1 known investors
Aramune Technologies develops natural plant-extracted compounds, added to animal feed, that modulate the immune system and gut microbiome to help livestock and companion animals resist harmful gut bacteria. Its products target monogastric commercial livestock such as pigs, poultry, farmed fish and crustacea, as well as companion animals like dogs and cats, positioned as a replacement for the banned antimicrobial Zinc Oxide.